Amplia and ANZGOG Finalise Protocol HIGHLIGHTS The PRROSE trial will investigate the combination of narmafotinib with standard of care chemotherapy in patients with advanced ovarian cancer Following close collaboration between ANZGOG and Amplia the clinical trial protocol [...]
Australia's National Gynaecological Cancer Roundtable Charts United Path Forward on Women's Health Sector leaders, government and women with lived experience unite in Canberra to accelerate evidence-based action, as diagnoses are set to rise 21 per cent over [...]
Call for Australians to help shape the future of gynaecological cancer care Every day in Australia, 19 people are diagnosed with a gynaecological cancer, including ovarian, uterine/endometrial, cervical, vulvar and vaginal cancers, and tragically, six people lose [...]
ANZGOG opens 2026 Fund for New Research Grants to accelerate the next generation of gynaecological cancer research The next breakthrough in gynaecological cancer treatment or care could begin with a research question that has not yet been [...]
ANZGOG leadership transition after 15 years of transformative growth The Australia New Zealand Gynaecological Oncology Group (ANZGOG) today announced its planned leadership transition, with Chief Executive Officer Alison Evans stepping down after close to 15 years [...]
ANZGOG contributes to global GCIG Code of Conduct on diversity in gynaecological cancer clinical trials ANZGOG has contributed to a new international publication in the International Journal of Gynecological Cancer introducing the GCIG Code of Conduct [...]
Simone Crerar remembered for her strength, kindness and courage Loved one’s honour Simone and call for greater awareness of and better clinical protocols for uterine cancers. Simone Crerar was born in Sydney in 1968 and grew [...]
Australia’s fastest-growing women’s cancer is largely preventable — yet most women have never heard of it MEDIA RELEASE 1 June 2026 National data confirms uterine cancer incidence has more than doubled in 25 years, with diagnoses among younger [...]
Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains MEDIA RELEASE 13 May 2026 Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains The Australia New Zealand Gynaecological Oncology Group [...]
AMPLIA THERAPEUTICS AND AUSTRALIA NEW ZEALAND GYNAECOLOGICAL ONCOLOGY GROUP (ANZGOG) ANNOUNCE OVARIAN CANCER STUDY Media Release - 8 May 2026 Highlights Amplia and ANZGOG enter into agreement to conduct a clinical study in ovarian cancer evaluating narmafotinib in [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2026 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
